← Eichor
Condition: Drug Related Neoplasm Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Drug Related Neoplasm Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · 590 location(s) · SWOG Cancer Research Network · NCT03418961
Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients
NA · 1 location(s) · Dena h. Al-Tameemi · NCT07273812
Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06664528
Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT06864481
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
Phase N/A · 1 location(s) · BioDelivery Sciences International · NCT03720613
Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
NA · 14 location(s) · Fundación Instituto de Estudios de Ciencias de la Salud de C · NCT03711110
Photobiomodulation Therapy in the Management of Hand-foot Syndrome and Hand-foot Skin Reaction
NA · 2 location(s) · Jessa Hospital · NCT04979078
Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer
Phase N/A · 1 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT05830279
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction
Phase 1/Phase 2 · 1 location(s) · Texas Tech University Health Sciences Center · NCT03934905
Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer:
Phase N/A · 1 location(s) · Fundación Pública Andaluza para la Investigación Biomédica A · NCT07582887
The RolE of Prolonged Nightly faSTing to Improve Sleep and cOgnition in bREast Cancer Survivors
NA · 1 location(s) · Arizona State University · NCT06938555
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer
NA · 2 location(s) · Massachusetts General Hospital · NCT02290834
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Phase 4 · 4 location(s) · Silesian Centre for Heart Diseases · NCT05465031
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Phase 2 · 10 location(s) · Rutgers, The State University of New Jersey · NCT05559164
The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Hearing-Related Quality of Life
Phase N/A · 1 location(s) · Turku University Hospital · NCT06551857
Perioperative Treatment With Tranexamic Acid in Melanoma
Phase 3 · 5 location(s) · University of Aarhus · NCT05899465
Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib
Phase N/A · 1 location(s) · Hubei Cancer Hospital · NCT07264985
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
Phase N/A · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT02772367
Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and
Phase N/A · 1 location(s) · Centre Paul Strauss · NCT06443645
Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study
Phase N/A · 1 location(s) · University Medical Center Groningen · NCT05851053
Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients
Phase 2 · 1 location(s) · University Hospital, Akershus · NCT05732051
SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)
Phase 2 · 3 location(s) · Queensland Centre for Gynaecological Cancer · NCT06278857
JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year
NA · 1 location(s) · Women's College Hospital · NCT06930521
TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography
NA · 1 location(s) · Norwegian University of Science and Technology · NCT06310330
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
Phase 1/Phase 2 · 1 location(s) · University of California, Irvine · NCT04520139
Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
Phase N/A · 2 location(s) · University of Geneva, Switzerland · NCT05512169
ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
Phase N/A · 1 location(s) · University Hospital, Caen · NCT07191730
Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer
NA · 4 location(s) · Odense University Hospital · NCT05406635
A Study of Blood Pressure Control During Cancer Treatment
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06023576
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
Phase 1 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07319364
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.